Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract

Status Completed

Clinical Trial Summary

This is a performance study to test the sensitivity and specificity of the BioFire FilmArray Lower Respiratory Tract Infection (LRTI) Panel. The purpose of this study is to prospectively collect and test residual Bronchoalveolar lavage (BAL) and sputum specimens and generate performance data to support regulatory classification of the FilmArray LRTI as an in vitro diagnostic (IVD) in the US, European Union (EU), Canada, and other regions.

Clinical Trial Description

BioFire Diagnostics, LLC (BioFire; a bioMerieux company), has developed a polymerase chain reaction (PCR), high-resolution melting analysis instrument called the FilmArray. The FilmArray Lower Respiratory Tract Infection (LRTI) Panel is a test designed for use with the FilmArray that identifies common bacterial, viral, and fungal microorganisms as well as antimicrobial resistance gene targets associated with lower respiratory tract infections. The FilmArray LRTI Panel also provides quantitation for some bacterial analytes.

Clinical performance evaluations will be initiated at a minimum of three sites to determine the clinical performance of the FilmArray LRTI Panel for each of the analytes on the panel when testing bronchoalveolar lavage (BAL, including mini-BAL) and sputum (including endotracheal aspirates) specimens from subjects with suspected lower respiratory tract (LRT) infections. The intention is for these performance data to support regulatory classifications of the FilmArray LRTI Panel as an in vitro diagnostic device in the US, European Union (EU), Canada, and other regions. The study sites selected will have expertise in the diagnosis of LRTIs, and will be able to conduct the evaluation in accordance with this protocol and Good Clinical Practices (GCP). Prior to performing the prospective clinical evaluation, each participating site will have the necessary Institutional Review Board (IRB) or Ethics Committee (EC) reviews.

Specimens for inclusion in this study will be residual, de-identified BAL or sputum specimens leftover from clinician-ordered lower respiratory pathogen testing.

Comparator testing will be performed using de-identified specimen aliquots at a central reference laboratory and at BioFire.

This study is funded by BioFire Diagnostics, LLC. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03361670
Study type	Observational
Source	BioFire Diagnostics, LLC
Contact
Status	Completed
Phase	N/A
Start date	October 2016
Completion date	July 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03191071` - An Algorithm to Decide on Antibiotic Prescription in Lower Respiratory Tract Infection in Primary Care	N/A
Not yet recruiting	`NCT05534555` - Point of Care Testing Using FebriDx in Primary Care: a Mixed Methods Feasibility Study	N/A
Recruiting	`NCT05423847` - Triage UltraSound in Tb Endemic Regions
Completed	`NCT04239521` - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Terminated	`NCT04225897` - A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.	Phase 2
Recruiting	`NCT04829188` - Comparative Effectiveness of Readmission Reduction Interventions for Individuals With Sepsis or Pneumonia	N/A
Active, not recruiting	`NCT03460171` - Clinical Features, Outcome and Prognosis of Human Metapneumovirus (hMPV) Lower Respiratory Tract Infections in Adult Inpatients
Withdrawn	`NCT04267822` - Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV	Phase 2
Completed	`NCT02979626` - Evaluation of Moderate to Severe Influenza Outcomes in Children
Completed	`NCT04602234` - Diagnostic of Lower Respiratory Tract Infection by Lung Ultrasonography in General Practice	N/A
Completed	`NCT03379779` - Evaluation the Association of Microbiome Between Respiratory Tract Samples and Stool Samples in Pneumonic Patients Accompanied by Respiratory Failure
Completed	`NCT04320862` - COVID-19 Pandemic Response Network
Not yet recruiting	`NCT06331364` - TREATment of Lower Respiratory Tract Infection in Sri Lanka (TREAT-SL)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Prospective Clinical Evaluation of the FilmArray® Lower Respiratory Tract Infection (LRTI) Panel — LRTI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms